Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity

PLoS One. 2013 Nov 20;8(11):e81251. doi: 10.1371/journal.pone.0081251. eCollection 2013.

Abstract

Several arenaviruses can cause severe hemorrhagic fever (HF) in humans, representing a public health threat in endemic areas of Africa and South America. The present study characterizes the potent virucidal activity of the carboxamide-derivatized aromatic disulfide NSC4492, an antiretroviral zinc finger-reactive compound, against Junín virus (JUNV), the causative agent of Argentine HF. The compound was able to inactivate JUNV in a time and temperature-dependent manner, producing more than 99 % reduction in virus titer upon incubation with virions at 37 °C for 90 min. The ability of NSC4492-treated JUNV to go through different steps of the multiplication cycle was then evaluated. Inactivated virions were able to bind and enter into the host cell with similar efficiency as control infectious particles. In contrast, treatment with NSC4492 impaired the capacity of JUNV to drive viral RNA synthesis, as measured by quantitative RT-PCR, and blocked viral protein expression, as determined by indirect immunofluorescence. These results suggest that the disulfide NSC4492 targets on the arenavirus replication complex leading to impairment in viral RNA synthesis. Additionally, analysis of VLP produced in NSC4492-treated cells expressing JUNV matrix Z protein revealed that the compound may interact with Z resulting in an altered aggregation behavior of this protein, but without affecting its intrinsic self-budding properties. The potential perspectives of NSC4492 as an inactivating vaccinal compound for pathogenic arenaviruses are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Arenavirus / drug effects*
  • Arenavirus / physiology*
  • Cell Line
  • Chlorocebus aethiops
  • Disulfides / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Hydrazines / pharmacology*
  • RNA, Viral / genetics*
  • Temperature
  • Transcription, Genetic / drug effects*
  • Vero Cells
  • Virus Release / drug effects
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Disulfides
  • Hydrazines
  • NSC4492
  • RNA, Viral

Grants and funding

This research was supported by Agencia Nacional para la Promoción Científica y Tecnológica (PICT 0506/2011 and 1931/2008), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET- PIP 0467 and 0275) and Universidad de Buenos Aires (UBACyT 00145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.